Fig. 6
From: Aptamer functionalized nucleic acid nano drug for targeted synergistic therapy for colon cancer
(a) Fluorescence microscopy detection of FND-induced decrease in cell membrane potential (scale bar: 100 μm). (b and c) Flow cytometry detection of cell G2/M cycle arrest induced by FND (*p < 0.05, **p < 0.01). (d) Fluorescence microscopy detection of FND-induced increase in cellular ROS (scale bar: 100 μm). (e and f) Flow cytometry detection of FND-induced increase in cellular ROS (*p < 0.05, **p < 0.01)